Net Contents: 3 x 0.5 mL
ADP is for use in routine platelet aggregation studies for the evaluation of inherited or acquired platelet dysfunction, anti-platelet therapy or platelet activation.
Elicits Platelet Shape Change
Detect P2Y1, P2Y12, and IIb IIIa Inhibitors
Monitor LVAD Implant Effects on Platelet Function
Extended Three Year Shelf Life
Catalog No. 101312
When added to platelet rich plasma, ADP stimulates platelets to change their shape and aggregate.
Aggregation induced by exogenous ADP is referred to as primary aggregation and is reversible. Normal platelets will further respond by releasing endogenous ADP from their granules. Release of endogenous ADP results in a secondary wave of aggregation which is irreversible
YOU MAY ALSO BE INTERESTED IN: